(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Duodenal Neoplasm
Masonic Cancer Center, University of MinnesotaSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Duodenal Neoplasm cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
URSODEOXYCHOLIC ACID Radboud University Medical Center | Phase 2/3 | B |
Dfn-15 Radboud University Medical Center | Phase 2/3 | B |
HYDROMORPHON Masonic Cancer Center, University of Minnesota | Phase 2 | CCC |
Iopamidol Masonic Cancer Center, University of Minnesota | Phase 2 | CCC |
Octreotide Pamoate St. James's Hospital, Ireland | N/A | D |
Same molecule, other indications
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →